Gapping up
In reaction to strong earnings/guidance:
- TNK +16.5%, TDOC +15.5%, GTE +11.8%, STAA +10.9%, PDCO +10.2%, REZI +10.1%, ETSY +10%, PWR +9%, GTE +8.8%, NTRA +8.7%, FLY +8.3%, BOX +7.5%, ESTC +7.5%, ETRN +6.6%, GTN +6.6%, ADPT +6.3%, NDLS +6.1%, UPLD +5.9%, WPG +4.8%, SQ +4.5%, SYKE +4.5%, GCI +4.3%, GOLF +4.1%, SWX +4%, DDD +3.8%, JNCE +3.5%, CROX +3.3%, ERI +3.1%, FTI +3%, KDP +3%, LAUR +2.8%, IIPR +2.6%, IIPR +2.5%, RUBI +2.4%, LB +2.2%, ALLO +2.2%, BMRN +2.1%, BTI +2%, CHS +2%, ONEW +1.9%, FG +1.5%, ARNA +1.4%, CPE +1.4%, STAY +1%
M&A news:
- GCAP +65.7% (to be acquired by INTL FCStone Inc)
Other news:
- ETRN +6.6% (announces actions regarding EQT including acquisition)
- GILD +6.5% (to initiate two Phase 3 studies of remdesivir for COVID-19)
- ELOX +5.6% (appoints Dr. Gregory Williams as CEO; appoints Neil Belloff, Esq. as COO)
- NSIT +4.7% (authorizes the repurchase of up to $50 million of the Company's common stock)
- QGEN +4.2% (announces shipments of QIAstat-Dx test kits for SARS-CoV-2)
- LIVN +2.4% (announces research collaboration with Verily, an Alphabet (GOOG) company)
- ESPR +0.8% (confirms FDA Approval of the NEXLIZET)
- E +0.8% (announces Agogo 3 results that increase the size of the field to 1 billion barrels of oil in place and pave the way for its full field development with a third production hub)
- ALSN +0.6% (increases dividend)
Analyst comments:
- REGN +4.7% (initiated with an Overweight at Barclays)
- SQ +4.5% (upgraded to Buy from Hold at Canaccord Genuity)